Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis
Public ClinicalTrials.gov record NCT05096065. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Dose-finding Study to Evaluate the Pharmacodynamic (PD) Profiles and Efficacy of Different Dosing Regimens of Leuprolide Oral Tablets (Ovarest®) in Women With Endometriosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The pharmacodynamic endpoint of percentage of subjects with suppressed estradiol level (less than 20 pg/mL) on cycle day 29 is the primary endpoint of the study.
Study identification
- NCT ID
- NCT05096065
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 16 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 49 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 17, 2022
- Primary completion
- Apr 30, 2022
- Completion
- Apr 30, 2022
- Last update posted
- Mar 21, 2022
2022
United States locations
- U.S. sites
- 4
- U.S. states
- 4
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Physician Care Clinical Research, LLC | Sarasota | Florida | 34239 | Recruiting |
| Complete Healthcare for Women | Columbus | Ohio | 43231 | Recruiting |
| Tidewater Clinical Research | Norfolk | Virginia | 23502 | Recruiting |
| Seattle Clinical Research Center | Seattle | Washington | 98105 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Endometriosis trials
Other public records listing Endometriosis. Sorted by last update posted; newest first. Not a recommendation.
- NCT07728695: Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain Recruiting
- NCT05069740: Endometriosis and Microvascular Dysfunction: Role of Inflammation Recruiting
- NCT06477406: Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis Recruiting
- NCT06785129: Endometriosis and Migraine Recruiting
- NCT07679074: CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life Recruiting
- NCT07664956: Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05096065, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 21, 2022 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05096065 live on ClinicalTrials.gov.